Literature DB >> 15979780

Comparative analysis of base biases around the stop codons in six eukaryotes.

Qingpo Liu1.   

Abstract

Using full-length cDNA sequences, a comparative analysis of sequence patterns around the stop codons in six eukaryotes was performed. Here, it was showed that the codon immediately before and after the stop codons (defined as -1 codon and +1 codon, respectively) were much more biased than other examined positions, especially at the second position of -1 codons and the first position of +1 codons which were rich in As/Us and purines, respectively, for most species. The author speculated that strongly biased sequence pattern from position -2 to +4 might act as an extended translation termination signal. Translation termination was catalyzed by release factors that recognized the stop codons. The multiple amino acid sequence alignment of eukaryotic release factor 1 (eRF1) of 20 species showed that there were 16 residue sites that were strictly conserved, especially the invariant amino acids Ile70 and Lys71. Accordingly, it could be inferred that those candidate amino acids might involve in the recognition process. Moreover, the possible stop signal recognition hypothesis was also discussed herein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15979780     DOI: 10.1016/j.biosystems.2005.05.005

Source DB:  PubMed          Journal:  Biosystems        ISSN: 0303-2647            Impact factor:   1.973


  8 in total

1.  A meta-analysis of single base-pair substitutions in translational termination codons ('nonstop' mutations) that cause human inherited disease.

Authors:  Stephen E Hamby; Nick S T Thomas; David N Cooper; Nadia Chuzhanova
Journal:  Hum Genomics       Date:  2011-05       Impact factor: 4.639

Review 2.  Developing mRNA-vaccine technologies.

Authors:  Thomas Schlake; Andreas Thess; Mariola Fotin-Mleczek; Karl-Josef Kallen
Journal:  RNA Biol       Date:  2012-10-12       Impact factor: 4.652

3.  A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agents.

Authors:  Michal Caspi; Anastasia Firsow; Raja Rajkumar; Nir Skalka; Itay Moshkovitz; Ariel Munitz; Metsada Pasmanik-Chor; Hagar Greif; Dalia Megido; Revital Kariv; Daniel W Rosenberg; Rina Rosin-Arbesfeld
Journal:  J Mol Med (Berl)       Date:  2015-12-01       Impact factor: 4.599

4.  Novel In Silico mRNA vaccine design exploiting proteins of M. tuberculosis that modulates host immune responses by inducing epigenetic modifications.

Authors:  H Al Tbeishat
Journal:  Sci Rep       Date:  2022-03-17       Impact factor: 4.996

5.  Comparison of characteristics and function of translation termination signals between and within prokaryotic and eukaryotic organisms.

Authors:  Andrew G Cridge; Louise L Major; Alhad A Mahagaonkar; Elizabeth S Poole; Leif A Isaksson; Warren P Tate
Journal:  Nucleic Acids Res       Date:  2006-04-13       Impact factor: 16.971

6.  Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach.

Authors:  Taimoor Khan; Abbas Khan; Jawad Khaliq Ansari; Muzammil Hasan Najmi; Dong-Qing Wei; Khalid Muhammad; Yasir Waheed
Journal:  Molecules       Date:  2022-04-06       Impact factor: 4.411

7.  Efficient assembly and annotation of the transcriptome of catfish by RNA-Seq analysis of a doubled haploid homozygote.

Authors:  Shikai Liu; Yu Zhang; Zunchun Zhou; Geoff Waldbieser; Fanyue Sun; Jianguo Lu; Jiaren Zhang; Yanliang Jiang; Hao Zhang; Xiuli Wang; K V Rajendran; Lester Khoo; Huseyin Kucuktas; Eric Peatman; Zhanjiang Liu
Journal:  BMC Genomics       Date:  2012-11-05       Impact factor: 3.969

Review 8.  Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency.

Authors:  Sun Chang Kim; Simranjeet Singh Sekhon; Woo-Ri Shin; Gna Ahn; Byung-Kwan Cho; Ji-Young Ahn; Yang-Hoon Kim
Journal:  Mol Cell Toxicol       Date:  2021-09-20       Impact factor: 1.080

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.